Literature DB >> 1400869

Correlations of language abnormalities with localization of mutations in the beta-thyroid hormone receptor in 13 kindreds with generalized resistance to thyroid hormone: identification of four new mutations.

A J Mixson1, R Parrilla, S C Ransom, E A Wiggs, J H McClaskey, P Hauser, B D Weintraub.   

Abstract

Generalized resistance to thyroid hormone is an inherited disease characterized by unresponsiveness of pituitary and peripheral tissues to thyroid hormone. Genetic analysis of several kindreds linked this syndrome to the gene for the beta-form of the thyroid hormone receptor, and this led to the subsequent identification of various mutations in the ligand-binding domain of this receptor. In this region we now have found 4 new point mutations with reduced T3-binding affinities from separate kindreds by direct sequencing of polymerase chain reaction products. Similar to previously studied kindreds, the reduction in T3 binding of these four kindreds ranged from 2.5- to 5-fold, indicating that these are not neutral polymorphisms. Furthermore, the pattern of inheritance of these 4 kindreds is familial in 2, sporadic in 1, and unknown in 1. To date, 20 distinct mutations have been identified, of which 18 are clustered in 2 distinct topographical regions: 11 are within the tau i/dimerization subdomains of exon 9, and 7 are within the L2 subdomain of exon 10. The 4 newly identified mutations coupled to the 9 mutations our laboratory has previously identified provide new insights into the clinical aspects of generalized resistance to thyroid hormone. Kindreds with mutations in exon 9 compared with those in exon 10 have significantly more problems in language development, as manifested by articulation problems and/or wide discrepancies in verbal and performance IQs. Interestingly, marked variability in language deficiency as well as other clinical patterns were seen not only between kindreds but also within a kindred. Further identification and clinical correlations of new mutations will continue to enhance our understanding of the structure/function relationships and physiological role of the human thyroid hormone receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400869     DOI: 10.1210/jcem.75.4.1400869

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene.

Authors:  M P McDonald; R Wong; G Goldstein; B Weintraub; S Y Cheng; J N Crawley
Journal:  Learn Mem       Date:  1998 Sep-Oct       Impact factor: 2.460

Review 2.  Mutational Landscape of Resistance to Thyroid Hormone Beta (RTHβ).

Authors:  Paola Concolino; Alessandra Costella; Rosa Maria Paragliola
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

3.  The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing.

Authors:  A Baniahmad; X Leng; T P Burris; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

4.  Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormone.

Authors:  A J Mixson; P Hauser; G Tennyson; J C Renault; D L Bodenner; B D Weintraub
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 5.  Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone. First workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, U.K.

Authors:  P Beck-Peccoz; V K Chatterjee; W W Chin; L J DeGroot; J L Jameson; H Nakamura; S Refetoff; S J Usala; B D Weintraub
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

6.  Phenotypic variability in patients with generalised resistance to thyroid hormone.

Authors:  J Pohlenz; S Wirth; A Winterpacht; H Wemme; B Zabel; W Schönberger
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

Review 7.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

8.  Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.

Authors:  R Wong; X G Zhu; M A Pineda; S Y Cheng; B D Weintraub
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

9.  Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.

Authors:  Y Hayashi; T Sunthornthepvarakul; S Refetoff
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

10.  Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene.

Authors:  M Adams; C Matthews; T N Collingwood; Y Tone; P Beck-Peccoz; K K Chatterjee
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.